GTMB 7 - Gene Therapy & Molecular Biology

More documents

Recommendations

Info

George et al: Gene therapy for vascular diseasesDichek DA, Anderson J, Kelly, A.B, Hanson S, Harker L (1996)Enhanced in vivo antithrombotic effects of endothelial cellsexpressing recombinant plasminogen activators transducedwith retroviral vectors. Circulation 93, 301-309.Dishart K, Denby, L, George S, Nicklin S, Yendluri S, Tuerk, M,Kelley, M, Donahue B, Newby, A, Harding T, Baker A(2003) Third-generation lentivirus vectors efficientlytransduce and phenotypically modify vascular cells:implications for gene therapyapy. J Mol Cell Cardiol 35,739-748.Dobrzynski E, Yoshida H, Chao J (1999) Adenovirus-mediatedkallikrein gene delivery attenuates hypertension and protectsagainst renal injury in deoxycorticosterone-salt rats.Immunopharmacology 44, 57-65.Dobrzynski E, Wang C, Chao J (2000) Adrenomedullin genedelivery attenuates hypertension cardiac remodeling andrenal injury in deoxycorticosterone acetate-salt hypertensiverats. Hypertension 36, 995-1001.Dunn P, Newman K.D, Jones M, Yamada I, Shayani V, VirmaniR, Dicheck, D (1996) Seeding of vascular grafts withgenetically modified endothelial cells. Secretion ofrecombinant TPA results in decrease seeded cell retention invitro and in vivo. Circulation 93, 1439-1446.Dzau V, Mann M, Morishita R, Kaneda Y (1996) Fusigenic viralliposome for gene therapy in cardiovascular diseases. ProcNatl Acad Sci USA 93, 11421-11425.Ehsan A, Mann M, Dell'Acqua G, Dzau V (2001) Long-termstabilization of vein graft wall architecture and prolongedresistance to experimental atherosclerosis after E2F decoyoligoneucleotide Gene Ther. J Thorac Cardiovasc Surg121, 714-722.Ehsan A, Mann M, Dell'Acqua G, Tamura K, Braun-Dullaeus R,Dzau V (2002) Endothelial healing in vein grafts.Proliferative burst unimpaired by genetic therapy ofneointimal disease. Circulation 105 (1686-1692).Emanueli C, Madeddu P (2001) Angiogenesis Gene Ther torescue ischaemic tissues: achievements and furturedirections. Br J Pharm 133, 951-958.Emanueli C, Salis M, Pinna A, Stacca T, Milia A, Spano A, ChaoJ, Chao L, Sciola L, Madeddu P (2002) Prevention ofdiabetes-induced microangiopathy by human tissue kallikreingene transfer. Circulation 106, 993 - 999.Engelhardt J.F, Litzky, L, Wilson J (1994) Prolonged transgeneexpression in cotton rat lung with recombinant adenovirusesdefective in E2a. Human Gene Ther 5, 1217-1229.Engelse MA, Lardenoye JP, Neele J, Grimbergen J, de VriesM.R, Lamfers M, Pannekoek, H, Quax, P, deVries C M(2002) Adenoviral activin A expression prevents intimalhyperplasia in human and murine blood vessels bymaintaining the contractile smooth muscle cell phenotype.Circ Res 90, 1128-1134.Fennell J.P, Brosnan M, Frater A, Hamilton CA, Alexander M.Y,Nicklin SA, Heistad D.D, BAker A, Dominiczak, A.F (2002)Adenovirus-mediated overexpression of extracellularsuperoxide dismutase improves endothelial dysfunction in arat model of hypertension. Gene Ther 9, 110-117.Fox, J (2003) US authorities uphold suspension of SCID GeneTher. Nat Biotechnol 21, 217-217.French, B, Mazur W, Ali N, Geske R, finnigan J, Rodgers G,Roberts R, Raizner A (1994a) Percutaneous transluminal invivo gene transfer by recombinant adenovirus in normalporcine coronary arteries atherosclerotic arteries and twomodels of coronary restenosis. Circulation 90, 2402-2413.French, BA, Mazur W, Geske R, Bolli R (1994b) Direct in vivogene transfer into procine myocardium using replicationdeficientadenoviral vectors. Circulation 90, 2414-2424.Furman C, Luo Z, Walsh, K, Duverger N (2002) Sytemic tissueinhibitor of metalloproteinase-1 gene delivery reducesneointimal hyperplasia in balloon-injured rat carotid artery.FEBS Letters 531, 122-126.Gangadharan S, Imai M, Rhynhart K, Sevigny, J, Robson S,Conte M (2001) Targeting platelet aggregation: CD39 genetransfer augments nucleoside triphosphatediphosphohydrolase activity in injured rabbit arteries.Surgery 130, 296-303.George S, Capogrossi M Angelini G, Baker A (2001) Wild typep53 gene transfer inhibits neointima formation in humansaphenous vein by modulation of smooth muscle cellmigration and induction of apoptosis. Gene Ther 8, 668-676.George S, Johnson J, Angelini G.D, Newby, A, Baker A (1998)Adenovirus-mediated gene transfer of the human TIMP-1gene inhibits SMC migration and neointima formation inhuman saphenous vein. Human Gene Ther 9, 867-877.George S, Lloyd C Angelini G.D, Newby, A, Baker A (2000)Inhibition of late vein graft neointima formation in humanand porcine models by adenovirus-mediated overexpressionof tissue inhibitor of metalloproteinase-3. Circulation 101,296-304.George S, Zaltsman A.B, Newby, A.C (1997) Surgicalpreparative injury and neointima formation increase MMP-9expression and MMP-2 activation in human saphenous vein.Cardiovasc Res 33, 447-459.George S, Baker A, Angelini G, Newby, A.C (1998) Genetransfer of tissue inhibitor of metalloproteinase-2 inhibitsmetalloproteinase activity and neointima formation in humansaphenous veins. Gene Ther 5, 1552-1560.Gossen M, Bujard H (1992) Tight control of gene expression inmammalian cells by tetracycline-responsive promoters. ProcNatl Acad Sci USA 89, 5547-5551.Grines C, Watkins M, Helmer G, Penny, W, Brinker J, JD M,West A, Rade J, Marrott P, Hammond H, Engler R (2002)Angiogenic Gene Therapy (AGENT) trial in patients withstable angina pectoris. Circulation 105, 1291-1297.Guzman R, Hirschowitz, EA, Brody, S, Crystal R, Epstein S.E,Finkel T (1994) In-vivo suppression of injury-inducedvascular smooth-muscle cell accumulation using adenovirusmediatedtransfer of the herpes-simplex virus thymidinekinase gene. Proc Natl Acad Sci USA 91 (22), 10732-10736.Hammond H.K, McKirman M (2001) Angiogenic Gene Therapyfor heart disease: a review of animal studies and clinicaltrials. Cardiovasc Res 49, 561-567.Hanna A.K, Fox, J Neschis D, Safford S.D, Swain J, Golden M(1997) Antisense basic fibroblast growth factor gene transferreduces neointimal thickening after arterial injury. J VascSurg 25, 320-325.Harrell R, Rajanayagam, S, Doanes A, Guzman R, Hirschowitz,EA, Crystal R, Epstein S.E, Finkel T (1997) Inhibition ofvascular smooth muscle cell proliferation and neointimalaccumulation by adenovirus-mediated gene transfer ofcytosine deaminase. Circulation 96, 621-627.Hart S, Collins L, Gustafsson K, Fabre J (1997) Integrinmediatedtransfection with peptides containing arginineglycine-asparticacid domains. Gene Ther 4, 1225-1230.Havenga M E, Lemckert A C, Grimbergen J, Vogels R, HuismanL, Valerio D, Bout A, Quax, P.H (2001) Improved146
Gene Therapy and Molecular Biology Vol 7, page 147adenovirus vectors for infection of cardiovascular tissues. J.Virol. 75, 3335-3342.Havenga M, Lemckert A, Ophorst O, Meijer M, Germeraad W,Grimbergen J, Doel M, Vogels R, Duetekom, J, Janson A,Bruijn J, Uytdehaag F, Quax, P, Logtenberg T, Mehtali M,Bout A (2002) Exploiting the natural diversity in adenovirustropism for therapy and prevention of disease. Virology 76,4612 - 4620.Hedman M, Hartikainen J, Syvanne M, Stjernvall J, Hedman A,Kivela A, Vanninen E, Mussalo H, Kauppila E, S S,Narvanen O, Rantala A, Peuhkurinen K, Nieminen M,Laakso M, Yla-Herttuala S (2003) Safety and feasibility ofcatheter-based local intracoronary vascular endothelialgrowth factor gene transfer in the prevention ofpostangioplasty and in-stent restenosis and in the treatmentof chronic myocardial ischemai. Phase II results of theKupoio Angiogenesis Trial (KAT) Circulation 107, 2677-2683.Hiltunen M.O, Turunen M.P, Turunen A.-M, Rissanen TLaitinen M, Kosma V.-M, Yla-Herttuala S (2000)Biodistribution of adenoviral vector to nontarget tissues afterlocal in vivo gene transfer to arterial wall using intravascularand periadventitial gene delivery methods. FASEB Journal14, 2230-2236.Hu Y, Baker A, Zou Y, Newby, A, Xu Q (2001) Local genetransfer of tissue inhibitor of metalloproteinase-2 influencesvein graft remodeling in a mouse model. ArteriosclerThromb Vasc Biol 21, 1275-1280.Huang J, Frischer J, Serur A, Kadenhe A, Yokoi A, McCruddenK, New, T, O'Toole K, Zabski S, Rudge J, Holash, J,Yancopoulos G, Yamashiro D, Kandel J (2003) Regressionof established tumors and metastases by potent vascularendothelial growth factor blockade. Proc Natl Acad SciUSA 100, 7785-7790.Iaccarino G, Smithwick, L, Lefkowitz, R, Koch, W (1999)Targetting Gbeta gamma signaling in arterial vascularsmooth muscle proliferation: a novel strategy to limitrestenosis. Proc Natl Acad Sci USA 96, 3945-3950.Igarashi T, Miyake K, Kato K, Watanabe A, Ishizaki M, OharaK, Shimada T (2003) Lentivirus-mediated expression ofangiostatin efficiently inhibits neovascularization in a murineproliferative retinopathy model. Gene Ther 10, 219-226.Isner J, Pieczek, A, Schainfeld R, Blair R, Haley, L, Asahara T,Rosenfield K, Razvi S, Walsh, E, Symes J.F (1996) Clinicalevidence of angiogenesis after arterial gene transfer ofphVEGF (165) in patient with ischaemic limb. Lancet 348,370-374.Janssen S, Flaherty, D, Nong Z, Varenne O, Van Pelt N,Haustermans C, Zoldhelyi P, Gerard R, Collen D (1998)Human endothelial nitric oxide synthase gene transferinhibits vascular smooth muscle cell prolifeation andneointima formation after balloon injury in rats. Circulation97, 1274-1281.Jayakumar J, Suzuki K, Khan M, Smolenski R, Farrell A, LatifN, Raisky, O, Abunasra H, Sammut I, Murtuza B, AmraniM, Yacoub M (2000) Gene therapy for myocardialprotection: transfection of donor hearts with heat shockprotein 70 gene protects cardiac function against ischemiareperfusioninjury. Circulation 102 (19 suppl 3), III302-III306.Katovich, M, Gelband C, Reaves P (1999) Reversal ofhypertension by angiotensin II type 1 receptor antisense genetherapy in the adult SHR. Am J Physiol 277, H1260-H1264.Kibbe M.R, Tzeng E, Gleixner S, Watkins S, Kovesdi L,Lizonova A, Makaroun M, Billiar T, Rhee R (2001)Adenovirus-meidated gene transfer of human inducible nitricoxide synthase in porcine vein grafts inhibits intimalhyperplasia. J Vasc Surg 34, 156-165.Kimura B, Mohuczy, D, Tang X, Phillips I (2001) Attenuation ofhypertension and heart hypertrophy by adeno-associatedvirus delivering angiotensinogen antisense. Hypertension37, 376 - 380.Klugherz, B, Song C, Defelice S, Cui X, Lu Z, Connolly, J,Hinson J, Wilensky, R, Levy, R (2002) Gene delivery to pigcoronary arteries from stents carrying antibody-tetheredadenovirus. Human Gene Ther 13, 443 - 454.Klugherz, B.D, Jones P, Cui X, Chen W, Meneveau N.F,DeFelice S, Connolly J, Wilensky, R, Levy, R (2000) Genedelivery from a DNA controlled-release stent in porcinecoronary arteries. Nat Biotechnol 18 (11), 1181-4.Kochanek, S, Clemens P.R, Mitani K, Chen H.-H, Chan S,Caskey, C. (1996) A new adenoviral vector: replacement ofall viral coding sequences with 28kb of DNA independentlyexpressing both full-length dystrophin and B-galactosidase.Proc Natl Acad Sci USA 93, 5731-5736.Koike H, Morishita R, Iguchi S, Aoki M, Matsumoto K,Nakamura T, Yokoyama C, Tanabe T, Ogihara T, Kaneda Y(2003) Enhanced angiogenesis and improvement ofneuropathy by cotransfection of human hepatocyte growthfactor and prostacyclin synthase gene. FASEB Journal 17,779-781.Laitinen M, Hartikainen J, Hiltunen M.O, Eranen J, KiviniemiM, Narvanen O, Makinen K, Manninen H, Syvanne M,Martin J.F, Laakso M, Yla-Herttuala S (2000) Cathetermediatedvascular endothelial growth factor gene transfer tohuman coronary arteries after angioplasty. Human GeneTher 11, 263-270.Lamfers M, Lardenoye J, de Vries M.R, Aalders M, EngelseMA, Grimbergen J, van Hinsbergh, V, Quax, P (2001) Invivo suppression of restenosis in balloon-injured rat carotidartery by adenovirus-mediated gene transfer of the cellsurface-directed plasmin inhibitor ATF.BPTI. Gene Ther 8,534-541.Lawrie A, Brisken A, Francis S, Tayler D, Chamberlain J,Crossman D, Cumberland D, Newman C (1999) UltrasoundEnhances Reporter Gene Expression After Transfection ofVascular Cells In Vitro. Circulation 99, 2617-2620.Lee R, Springer M, Blanco-Bose W.E, Shaw, R, Ursell P Blau H(2000) VEGF Gene Delivery to Myocardium: DeleteriousEffects of Unregulated Expression. Circulation 102, 898-901.Lemarchand P, Jones M, Yamada I, Crystal R (1993) In vivogene transfer and expression in normal uninjured bloodvessels using replication-deficient recombinant adenovirusvectors. Circ Res 72, 1132-1138.Li JM, Brooks G (1999) Cell cycle regulatory molecules (cyclinscyclin-dependent kinases and cyclin dependent kinaseinhibitors) and the cardiovascular system. Potential targetsfor therapy? Eur Heart J 20, 406-420.Li Q, Bolli R, Qiu Y, Tang X, Guo Y, French, B (2001) Genetherapy with extracellular superoxide sismutase protectsconscious rabbits against myocardial infarction. Circulation103, 1893-1898.Lin K.F, Chao J, Chao L (1995) Human atrial natriuretic peptidegene delivery reduces blood pressure in hypertensive rats.Hypertension 26, 847-853.Lin K.F, Chao L, Chao J (1997) Prolonged reduction of highblood pressure with human nitric oxide synthase genedelivery. Hypertension 30, 307-313.147
Page 7 and 8:
Instructions to authors:Gene Therap
Page 9:
Please submit an electronic version
Page 12:
103-111 ResearchArticle113-133 Revi
Page 17 and 18:
Gene Therapy and Molecular Biology
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77:
Page 80 and 81:
Epperly et al: Late injection of Mn
Page 82 and 83:
Epperly et al: Late injection of Mn
Page 84 and 85:
Goldberg-Cohen et al: Regulation of
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Gascón-Irún et al: Gene therapy a
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Suzuki et al: Regulation of the Sp/
Page 108 and 109:
Suzuki et al: Regulation of the Sp/
Page 110 and 111: Suzuki et al: Regulation of the Sp/
Page 112 and 113: Suzuki et al: Regulation of the Sp/
Page 114 and 115: Li et al: MET amplification in live
Page 116 and 117: Li et al: MET amplification in live
Page 118 and 119: Chavakis et al: Leukocyte adhesion
Page 128 and 129: Sanlioglu et al: Adenovirus mediate
Page 150 and 151: George et al: Gene therapy for vasc
Page 168 and 169: Zhang et al: Angiogenic Gene Therap
Page 182 and 183: Xu et al: G-CSF receptor-mediated S
Page 188 and 189: Burek et al: Calcium induced cell d
Page 196 and 197: David et al: Current status and fut
Page 210 and 211:
David et al: Current status and fut
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Stoll et al: The role of EBV and ge
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Maruyama et al: Kidney-targeted pla
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Kren et al: Hepatocyte-targeted del
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Zeng: PRL-3 as a target for cancer
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Latchman: Protective effect of heat
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Cai et al: Lung cancer gene therapy
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309:
show all

GTMB 7 - Gene Therapy & Molecular Biology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?